The efficacy of aspirin versus low‐molecular‐weight heparin for venous thromboembolism prophylaxis after knee and hip arthroplasty: A systematic review and meta‐analysis of randomized controlled trials
Wirksamkeit von Aspirin versus niedermolekularem Heparin zur VTE-Prophylaxe nach Knie- und Hüftarthroplastie: systematische Übersicht und Metaanalyse randomisierter kontrollierter Studien
Knee Surgery, Sports Traumatology, Arthroscopy · 2025-05 · 33 (5) · 1605-1616
DOI: 10.1002/ksa.12456 ↗Auf einen Blick
Sieben RCTs zeigen nach Hüft- oder Kniearthroplastie keinen Unterschied im Gesamtrisiko für VTE zwischen Aspirin und LMWH. In Subanalysen war das PE-Risiko unter Aspirin höher.
Fragestellung
Ist Aspirin zur VTE-Prophylaxe nach Hüft- und Kniearthroplastie ebenso wirksam wie niedermolekulares Heparin?
Methode
Systematische Übersicht und Metaanalyse von RCTs; Suche in PubMed/Medline, Embase, Cochrane Library und Google Scholar bis Juni 2024.
Ergebnisse
7 RCTs mit 12.134 Teilnehmenden. Kein Unterschied im Gesamt-VTE-Risiko: OR 0,95 (95 %-KI 0,48–1,89; p=0,877). PE: OR 1,79 (95 %-KI 1,11–2,89; p=0,017).
Schlussfolgerung der Autor:innen
Die Studie zeigte ein signifikant höheres PE-Risiko unter Aspirin im Vergleich zu LMWH nach Hüft- oder Kniearthroplastie. Nach Kniearthroplastie war das VTE-Risiko unter Aspirin ebenfalls höher.
Kernaussagen
- Gesamt-VTE: kein signifikanter Unterschied zwischen Aspirin und LMWH
- PE-Risiko unter Aspirin höher: OR 1,79 (95 %-KI 1,11–2,89)
- Bei Kniearthroplastie war das VTE-Risiko unter Aspirin höher
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift Knee Surgery, Sports Traumatology, Arthroscopy, online erschienen am 03.09.2024. Verfasst von Loay A Salman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Surgical Specialty Center, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar. Hauptthemen laut MEDLINE: Heparin, Low-Molecular-Weight, Venous Thromboembolism, Arthroplasty, Replacement, Knee, Aspirin. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Purpose
The purpose of this study was to assess the efficacy of aspirin versus low‐molecular‐weight heparin (LMWH) in preventing venous thromboembolism (VTE) following hip and knee arthroplasty.
Methods
PubMed/Medline, Embase, Cochrane Library and Google Scholar databases were searched from inception till June 2024 for original trials investigating the outcomes of aspirin versus LMWH in hip and knee arthroplasty. The primary outcome was VTE. Secondary outcomes included minor and major bleeding events, and postoperative mortality within 90 days. This review was conducted per the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines.
Results
A total of 7 randomized controlled trials with 12,134 participants were included. The mean ages for the aspirin and LMWH cohorts were 66.6 (57.6–69.0) years and 66.8 (57.9–68.9) years, respectively. There was no statistically significant difference in the overall risk of VTE between the aspirin and the LMWH cohorts (odds ratio [OR]: 0.95; 95% confidence interval [CI]: 0.48–1.89; p : 0.877). A subanalysis based on the specific VTE entity (pulmonary embolism [PE] or deep venous thrombosis) showed a significantly higher PE risk for patients receiving aspirin than the LMWH cohort (OR: 1.79; 95% CI: 1.11–2.89; p : 0.017). There was no difference in minor (OR: 0.64; 95% CI: 0.40–1.04; p : 0.072) and major bleeding (OR: 0.77; 95% CI: 0.40–1.47; p : 0.424) episodes across both groups. Furthermore, subanalysis among the total knee arthroplasty group showed that the aspirin cohort was significantly more likely to suffer VTEs than their LMWH counterparts (OR: 1.55; 95% CI: 1.21–1.98; p < 0.001).
Conclusion
This study demonstrated a significantly higher risk of PE among patients receiving aspirin compared to LMWH following hip or knee arthroplasty for osteoarthritis. Aspirin was associated with a significantly higher overall VTE risk among patients undergoing knee arthroplasty, in particular. This might suggest the inferiority of aspirin compared to LMWH in preventing VTE following such procedures. Level of Evidence Level I.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Surgical Specialty Center, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
- Royal London Hospital, London, UK.
- Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman, Jordan.
- Nuffield Orthopaedic Centre, University of Oxford, Oxford, UK.
Zitieren
APA
Salman, L. A., Altahtamouni, S. B., Khatkar, H., Al-Ani, A., Hameed, S., & Alvand, A. (2025). The efficacy of aspirin versus low‐molecular‐weight heparin for venous thromboembolism prophylaxis after knee and hip arthroplasty: A systematic review and meta‐analysis of randomized controlled trials. Knee Surgery, Sports Traumatology, Arthroscopy, 33(5), 1605-1616. https://doi.org/10.1002/ksa.12456
Vancouver
Salman LA, Altahtamouni SB, Khatkar H, Al-Ani A, Hameed S, Alvand A. The efficacy of aspirin versus low‐molecular‐weight heparin for venous thromboembolism prophylaxis after knee and hip arthroplasty: A systematic review and meta‐analysis of randomized controlled trials. Knee Surgery, Sports Traumatology, Arthroscopy. 2025;33(5):1605-1616. doi:10.1002/ksa.12456
BibTeX
@article{Salman2025,
author = {Salman, Loay A and Altahtamouni, Seif B and Khatkar, Harman and Al-Ani, Abdallah and Hameed, Shamsi and Alvand, Abtin},
title = {The efficacy of aspirin versus low‐molecular‐weight heparin for venous thromboembolism prophylaxis after knee and hip arthroplasty: A systematic review and meta‐analysis of randomized controlled trials},
journal = {Knee Surgery, Sports Traumatology, Arthroscopy},
year = {2025},
volume = {33},
number = {5},
pages = {1605--1616},
doi = {10.1002/ksa.12456}
}
EUVIMED